Sort
15,273 grants matching “antimicrobial resistance”
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN
$389,093Marco Colonna · Washington University · R01 · FY2024 · DK
A High-Throughput Screen for Specific Anti-M. tuberculosis Compounds
$388,958Kim Lewis · Northeastern University · R01 · FY2010 · AI
Nitric Oxide and Severe Malaria
$388,951Duke University · R01 · FY2003 · AI
Structure-based discovery and design of novel class D beta-lactamase inhibitors
$388,758Rachel Powers · Grand Valley State University · R15 · FY2014 · AI
Biochemical Investigations of Sugar-Modifying Enzymes
$388,750Hazel Holden · University Of Wisconsin-Madison · R35 · FY2024 · GM
Biochemical Investigations of Sugar-Modifying Enzymes
$388,750Hazel Holden · University Of Wisconsin-Madison · R35 · FY2023 · GM
Biochemical Investigations of Sugar-Modifying Enzymes
$388,750Hazel Holden · University Of Wisconsin-Madison · R35 · FY2022 · GM
THE SALMONELLA TYPHIMURIUM SIGMAE REGULON
$388,750Ferric C Fang · University Of Washington · R01 · FY2006 · AI
Pharmacodynamic modeling of antibiotics on cystic fibrosis P. aeruginosa biofilms
$388,641Katherine Y. Yang · University Of California, San Francisco · R01 · FY2014 · AI
Predictive Modeling of Influenza-Pneumococcal Coinfection
$388,577Amber M Smith · University Of Tennessee Health Sci Ctr · R01 · FY2022 · AI
Extracellular Replication of Listeria in Vivo
$388,564Christopher H Contag · Stanford University · R01 · FY2009 · DK
HIV Drugs and Their Impact on Malaria Infection and Immunity
$388,431Charlotte Hobbs · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Biology of Infectious Diseases Training Program
$388,425Matthew G Dorsey · University Of California, San Francisco · T32 · FY2025 · AI
Ohio State Health Network Infection Control Collaborative
$388,360Kurt B Stevenson · Ohio State University · U01 · FY2008 · CI
Cytoskeletal Keratins in Epithelial Immunity to Bacterial Keratitis
$388,325K. P. Connie Tam · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · EY
Pharmacodynamic modeling of antibiotics on cystic fibrosis P. aeruginosa biofilms
$388,286Katherine Y. Yang · University Of California, San Francisco · R01 · FY2015 · AI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy
$388,268Berthony Deslouches · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · GM
Pharmacodynamic modeling of antibiotics on cystic fibrosis P. aeruginosa biofilms
$388,250Katherine Y. Yang · University Of California, San Francisco · R01 · FY2016 · AI
Biochemical Investigations of Sugar-Modifying Enzymes
$388,229Hazel Holden · University Of Wisconsin-Madison · R35 · FY2021 · GM
ANTIMICROBIAL TECHNOLOGY TO ACTIVELY MITIGATE HYDROCEPHALUS SHUNT INFECTIONS LONG TERM
$388,161Marion Walker · Thrombodyne, Inc. · R43 · FY2020 · NS
Molecular Biology and Virulence of CTX Phage
$388,133Matthew K Waldor · Brigham And Women'S Hospital · R37 · FY2013 · AI
Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide
$388,125Xuewei Wang · Virginia Commonwealth University · R01 · FY2025 · HL
Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide
$388,125Xuewei Wang · Virginia Commonwealth University · R01 · FY2024 · HL
Task C06: Lung Microphysiological Systems as Models of Infectious Diseases for BSL-3 Pathogens
$388,097David Beasley · University Of Texas Med Br Galveston · N01 · FY2019 · AI
Effect of Bacteria and Mechanical Loading on Degradation of the Composite-Tooth I
$388,074Jack L. Ferracane · Oregon Health & Science University · R01 · FY2010 · DE